MedLumics: Series A $4.7M

Posted in I - Series A, Q - 4Q11, R - INTERNATIONAL, X - Device (Imaging), X - Device (Ophthalmology)

MedLumics (Spain) a development-stage diagnostic device company focused on optical coherence tomography imaging for ophthalmology and intravascular imaging in cardiology, dermatology and dentistry, closed a $3.25M Series A financing. Participants include Ysios Capital Partners and Caixa Capital.

Oct

2011

AM-Pharma, NV: Series D $39.8M

Posted in I - Series D, Q - 3Q11, R - INTERNATIONAL, X - IBD, X - Renal

AM-Pharma (The Netherlands) a clinical-stage pharmaceutical company focused on acute kidney injury and ulcerative colitis, closed a $39.8M Series D financing. Participants include Ysios Capital Partners, Kurma Life Science Partners, Abbott Ventures, Shire Ventures, BB Biotech Ventures, Idinvest Partners, Forbion Capital Partners and Inventages Venture Capital.

Jan

2010

Cellerix, SL: Series C $37.7M

Posted in I - Series C, Q - 4Q09, R - INTERNATIONAL, X - Crohn's, X - GI, X - Stem Cell

Cellerix (Spain) a clinical-stage biopharma company focused on adult stem cell therapies for Crohn’s and other GI diseases, closed a $37.7M Series C financing. Participants include Ysios Capital Partners, Ventech, Roche Venture Fund and Novartis Venture Fund.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Jan

2010

BioVex, Inc.: Series F $30M

Posted in I - Series F, Q - 4Q09, R - NORTH EAST, X - Biologics Mfg., X - Oncology, XX - MA

BioVex (Woburn, MA) a clinical-stage biologics company focused on metastatic melanoma, head and neck, pancreatic and colo-rectal cancer, closed a $30M Series F bringing the entire round to $70M. Participants have included Morningside Venture, Ventech, MVM Life Science Partners, Sectoral Asset Management, Ysios Capital Partners, Forbion Capital Partners, Credit Agricole Private Equity, Harris & Harris [...]

to top of page...